论文部分内容阅读
目的 观察丹奥对急性脑梗死的近期临床疗效。方法 将 2 0 4例脑梗死患者随机分为丹奥治疗组10 6例与复方丹参对照组 98例 ,治疗组给予丹奥 80 mg加入生理盐水 2 5 0 ml中静滴 ,每日 2次 ,共 14日 ;对照组给予低分子右旋糖酐 5 0 0 ml+复方丹参 2 0 ml静滴 ,每日 1次 ,共 14日 ;进行治疗前后临床疗效及实验室指标观察与比较。结果 治疗组的显效率和总有效率都显著高于对照组 (P<0 .0 1) ,治疗组的神经功能缺损评分减少程度显著高于对照组 (P<0 .0 1) ,治疗中无明显副作用。结论 丹奥治疗急性脑梗死安全有效 ,值得临床推广使用
Objective To observe the recent clinical effect of Danio on acute cerebral infarction. Methods Twenty-four patients with cerebral infarction were randomly divided into Danao treatment group (106 cases) and Salvia miltiorrhiza control group (98 cases). The treatment group was given Danao 80 mg intravenously in 250 ml normal saline twice daily, A total of 14 days; the control group was given low molecular weight dextran 500 ml + compound Danshen 20 ml intravenously once daily for 14 days; before and after treatment, clinical efficacy and laboratory indicators were observed and compared. Results The effective rate and total effective rate of the treatment group were significantly higher than those of the control group (P <0.01), and the reduction of the neurological deficit score of the treatment group was significantly higher than that of the control group (P <0.01) No obvious side effects. Conclusion Danio treatment of acute cerebral infarction safe and effective, it is worth to promote the use of the clinic